Anixa Biosciences Inc — Director's Dealing 2017

Apr 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-04-03

Reporting Person: BERMAN ROBERT ANDREW (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-03	Common Stock	X	5995	$2.38	Acquired	51553	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-03	Subscription Right	$2.38	X	5995	Disposed		Common Stock (5995)	Direct

Footnotes

F1: ITUS Corporation distributed to holders of its common stock and certain warrants, non-transferrable subscription rights to purchase one share of common stock for each share of common stock held on March 1, 2017. The rights offering expired on March 24, 2017, but the company did not close the rights offering until April 3, 2017.